Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Tchou J, Gottipati S, Goldbach M, Baxter M, et al. ASO Visual Abstract: Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and is Common in Patients with HER2+ Breast Cancer. Ann Surg Oncol 2024 Aug 19. doi: 10.1245/s10434-024-16090.
PMID: 39158642


Privacy Policy